Takatoshi Takubo

Phase I / II study of brentuximab vedotin in <scp>J</scp>apanese patients with relapsed or refractory <scp>CD</scp>30‐positive <scp>H</scp>odgkin's lymphoma or systemic anaplastic large‐cell lymphoma

Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake et al. · Cancer Science · 2014 · 54 citations · Full text

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto et al. · Cancer Chemotherapy and Pharmacology · 2012 · 29 citations · Full text

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Toshihiko Doi, Atsushi Ohtsu, Nozomu Fuse et al. · Cancer Chemotherapy and Pharmacology · 2012 · 21 citations · Full text

Effect of Trimethoprim on the Renal Clearance of Lamivudine in Rats

Takatoshi Takubo, Toshihiro Kato, Junji Kinami et al. · Journal of Pharmacy and Pharmacology · 2000 · 20 citations

Unchanged Drug, Urology, Minimal Metabolism +12

Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia

Xiaofei Zhou, Diane R. Mould, Takatoshi Takubo et al. · British Journal of Clinical Pharmacology · 2017 · 20 citations · Full text